Peter Heutnik, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE), Standort Tübingen, Tübingen - GERMANY - speaks on "CAGEseq expression profiling for genetically distinct forms of frontotemporal dementia(FTD) reveals common an

M. Strong - miRNA modulation of NEFL mRNA stability in ALS

May 28th, 2014 33m 9s

Michael Strong, Dean, Schulich School of Medicine & Dentistry, Distinguished University Professor, Western University, Rix Clinical Skills Learning Building, London - CANADA speaks on miRNA modulation of NEFL mRNA stability in ALS - RNA Metabol

D. Trotti - Neuronal toxicity of the ALS/FTD-linked GGGGCC repeat expansions within the C9ORF72 gene

May 28th, 2014 34m 6s

Davide Trotti, Department of Neuroscience & Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia - USA speaks on "Neuronal toxicity of the ALS/FTD-linked GGGGCC repeat expansions within the C9ORF72 gene - RNA Metabolism:

R. Baloh - Cellular and animal models to understand C9ORF72 repeat expansion in ALS and FTLD

May 28th, 2014 27m 47s

Robert Baloh, Cedars-Sinai, Director, Neuromuscular Medicine, ALS Program, Neurodegenerative Diseases Laboratory, Advanced Health Sciences Pavilion Los Angeles - USA speaks on "Cellular and animal models to understand C9ORF72 repeat expansion i

R. Baloh - Cellular and animal models to understand C9ORF72 repeat expansion in ALS and FTLD

May 28th, 2014 27m 47s

B. Rogelj - RNA-binding proteins that bind ALS- and FTLD-associated hexanucleotide repeat expansion mutation

May 28th, 2014 17m 45s

Boris Rogelj, Department of Biotechnology B3, Jozef Stefan Institute, Ljubljana - SLOVENIA speaks on "RNA-binding proteins that bind ALS- and FTLD-associated hexanucleotide repeat expansion mutation. This seminar has been recorded at Area Scien

S. Pickering-Brown - Cellular modeling of the C9orf72 repeat expansion

May 28th, 2014 25m 24s

Stuart Pickering-Brown, Professor of Neurogenetics and MRC Senior Research Fellow, Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester - UK speaks on "Cellular modeling of the C9orf72 repeat expansion - RNA Met

S. Pickering-Brown - Cellular modeling of the C9orf72 repeat expansion

May 28th, 2014 25m 24s

T. Shelkovnikova - Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms

May 28th, 2014 18m 53s

Tatyana Shelkovnikova, School of Biosciences, Sir Martin Evans Building, Cardiff - UK speaks on "Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms- RNA Metabolism: Changing Paradi

D. Morshedi - The presence of the fibrillar form of alpha-synuclein moderate dopamine cytotoxicity - RNA Metabolism: Changin Paradigms in Neurodegeneration

May 28th, 2014 20m 57s

Dina Morshedi, National Institute of Genetic Engineering and Biotechnology, Department of Industrial & Environmental Biotechnology, Tehran - IRAN. This seminar has been recorded at Area Science Park Trieste by ICGEB Trieste

P. Longone-Activity-dependent expression of heterogeneous nuclear ribonucleoprotein (hnRNP) mRNAs in neurons: regulated translation at the synapse

May 28th, 2014 10m 46s

Patrizia Longone, Laboratory Head, Fondazione Santa Lucia - Molecular Neurobiology, Rome - ITALY speaks on "Activity-dependent expression of heterogeneous nuclear ribonucleoprotein (hnRNP) mRNAs in neurons: regulated translation at the synapse

C. Lagier-Tourenne -Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration

May 28th, 2014 39m 1s

Clotilde Lagier-Tourenne, Assistant Investigator, Ludwig Institute for Cancer Research, Assistant Professor, Department of Neurosciences, University of California, San Diego, La Jolla - USA - speaks on "Targeted degradation of sense and antise

K. Talbot - Physiological models of TDP-43 related amyotrophic lateral sclerosis

May 27th, 2014 16m 49s

Kevin Talbot, Nuffield Department of Clinical Neurosciences, Medical Sciences Division, John Radcliffe Hospital, University of Oxford - UK speaks on Physiological models of TDP-43 related amyotrophic lateral sclerosis - RNA Metabolism: Changing

A. Acevedo-Arozena - Missense mutations in mouse Tardbp differentially affect TDP43 functions

May 27th, 2014 18m 15s

Abraham Acevedo Arozena, MRC Harwell, Harwell Science and Innovation Campus, Oxfordshire - UK speaks on "Missense mutations in mouse Tardbp differentially affect TDP43 functions - RNA Metabolism: Changing Paradigms in Neurodegeneration". This s

B. Schmid - In vivo function of TDP-43 in zebrafish

May 27th, 2014 23m 41s

Bettina Schmid, German Center for Neurodegenerative Diseases(DZNE), Munich - GERMANY speaks on "In vivo function of TDP-43 in zebrafish - RNA Metabolism: Changing Paradigms in Neurodegeneration".This seminar has been recorded at Area Science Pa

L. Muller-Igaz - Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies

May 27th, 2014 20m 18s

Lionel Muller-Igaz Principal Investigator (CONICET), Neuronal Physiopathology Laboratory, Physiology Departament, School of Medicine, University of Buenos Aires, Buenos Aires - ARGENTINA speaks on "Reversible behavioral phenotypes in a conditi

L. Errichelli - Role of 3’UTR of FUS in Amyotrophic Lateral Sclerosis disease

May 27th, 2014 13m 55s

Lorenzo Errichelli, Selargius (CA) ITALY speaks on "Role of 3’UTR of FUS in Amyotrophic Lateral Sclerosis disease".This seminar has been recorded at ICTP Trieste by ICGEB Trieste

E. So - An emerging role of FUS at the neuromuscular junction: implications for ALS and FTDpathogenesis

May 27th, 2014 27m 11s

Eva So, Kings’ College, Department of Clinical Neuroscience, Institute of Psychiatry, DeCreso, London - UK speaks on "An emerging role of FUS at the neuromuscular junction: implications for ALS and FTD pathogenesis". This seminar has been recor

L. Errichelli - Role of 3’UTR of FUS in Amyotrophic Lateral Sclerosis disease

May 27th, 2014 13m 55s

Lorenzo Errichelli, Selargius (CA) ITALY speaks on "Role of 3’UTR of FUS in Amyotrophic Lateral Sclerosis disease".This seminar has been recorded at ICTP Trieste by ICGEB Trieste

E. So - An emerging role of FUS at the neuromuscular junction: implications for ALS and FTDpathogenesis

May 27th, 2014 27m 11s

E. Buratti - New insights on TDP-43 structural and splicing processes

May 27th, 2014 31m 13s

Emanuele Buratti, Molecular Pathology Group Leader, ICGEB Trieste - ITALY speaks on "New insights on TDP-43 structural and splicing processes - RNA Metabolism: Changing Paradigms in Neurodegeneration". This seminar has been recorded at Area Sc

D. Dormann - Cellular stress impairs the physiological function of TDP-43

May 27th, 2014 18m 51s

Dorothee Dormann, Ludwig Maximilians Universität München, Adolf Butenandt Institute, Metabolic Biochemistry, Munich - GERMANY speaks on "RNA-binding proteins with prion-like domains in neurodegenerative diseases “RNA Metabolism: Changing Para

P. Kahle - UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 ubiquitinylation

May 27th, 2014 21m 20s

Philipp Kahle, Functional Neurogenetics, Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Faculty of Medicine, University of Tübingen - GERMANY speaks on "UBE2E ubi

F. E. Baralle - New insights in TDP-43 aggregation processes

May 27th, 2014 34m 14s

Francisco E. Baralle, Molecular Pathology Group, ICGEB Trieste - ITALY speaks on "New insights in TDP-43 aggregation processes - RNA Metabolism: Changing Paradigms in Neurodegeneration”. This seminar has been recorded at Area Science Park Trie

V. Silani - From TARDBP and FUS/TLS to C9orf72 in ALS/FTD: further changing paradigms in thegenotype-phenotype correlation

May 26th, 2014 35m 17s

Vincenzo Silani, Istituto Auxologico Italiano, U.O. Neurologia – Stroke Unit e Laboratorio Neuroscienze, Milano - ITALY speaks on "From TARDBP and FUS/TLS to C9orf72 in ALS/FTD: further changing paradigms in the genotype-phenotype correlation